BizDev.

Development and Commercialization of AI-Assisted Cervical Visualization Tools in LMICs

The Clinton Health Access Initiative (CHAI), with support from Unitaid, invites proposals for the late-stage development, validation, regulatory approval, manufacturing scale-up, and commercialization of AI-enabled assisted cervical visual triage (AI-ACVT) solutions to support cervical cancer elimination efforts in low- and middle-income countries (LMICs). Cervical cancer remains a leading cause of death among women globally, with more than 90% of deaths occurring in LMICs due to limited access to effective screening and treatment. AI-ACVT solutions offer a promising alternative by enabling real-time, point-of-care clinical decision support.

Through this RFP, CHAI seeks proposals for co-investment from organizations capable of commercializing, validating, and deploying AI-ACVT solutions in support of cervical cancer elimination. The aim is at least one quality-assured, regulatory-approved, affordable and sustainable AI-ACVT tool widely available across the African region.

About

NextBillion publishes free ads for business development opportunities available to enterprises working in low- and middle-income countries. These may include accelerators, competitions, funding opportunities, incubators, requests for proposals, and training courses. 
 
Please note: NextBillion is not the organizer of these opportunities, we do not perform in-depth vetting of individual opportunities or organizations, and we source many of them online. So plan to conduct your own due diligence before applying.
 
To submit an ad, click on the “Submit BizDev Opportunity” button above.
 

Connect

Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.
×
×